Avadel Pharmaceuticals plc
AVDL
$14.20
$0.201.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 296.44% | 2.44% | -92.11% | 81.01% | 49.45% |
| Total Depreciation and Amortization | 29.45% | 23.50% | -35.46% | 136.84% | -19.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.13% | -2.23% | -21.85% | 11.92% | 6.49% |
| Change in Net Operating Assets | 70.12% | -206.23% | 172.69% | -11.17% | -29.06% |
| Cash from Operations | 254.24% | -204.56% | 214.27% | 62.11% | 38.78% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -165.54% | -17.41% | 202.49% | -53.27% | -50.67% |
| Cash from Investing | -167.01% | -17.41% | 202.49% | -53.27% | -50.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 42.32% | -21.59% | -25.23% | 62.79% | -94.52% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 42.32% | -21.59% | -25.23% | 62.79% | -94.52% |
| Foreign Exchange rate Adjustments | 617.41% | 125.54% | -269.31% | 1,623.53% | 86.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 40.67% | -78.06% | 8,699.62% | 96.19% | -250.14% |